Yann D’Herve Appointed CEO of Cohance Lifesciences CDMO Business geneonline.comCohance Lifesciences appoints Yann D’Herve as CEO of CDMO business, effective August 1, 2025 Pharmabiz.comCohance Lifesciences appoints Yann D’Herve as CEO of CDMO Business People Matters – HR NewsCohance Lifesciences appoints Yann D’Herve as CEO of CDMO business Express Pharma
